Гелена Ариньш - Бойкот раку. Защитите себя и своих близких! Советы врача-онколога из Великобритании

55. Tashiro M, Itoh M, Kubota K, Kumano H, Masud MM, Moser E, Arai H, Sasaki H. Relationship between trait anxiety, brain activity and natural killer cell activity in cancer patients: a preliminary PET study. Psychooncology 2001; 10(6): 541–6.

56. House JS, Landis KR, Umberson D. Social relationship and health. Science 1988; 241: 540–5.

57. Reynolds P, Kaplan GA. Social connections and risk for cancer: prospective evidence from the Alameda county study. Behav Med 1990; 16: 101–10.

58. Phillips DP, Van Voorhees CA, Ruth TE. The birthday: lifeline or deadline? Psychosom Med 1992; 54: 532–42.

59. Phillips DP, Ruth TE, Wagner LM. Psychology and survival. Lancet 1993; 342: 1142–5.

60. Penninx BW. Chronically depressed mood and cancer risk in older persons. Journal of the National Cancer Institute 1998; 90: 1888–93.

61. Giese-Davis J, Collie K, Rancourt KM, et al. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncology 2011; 29: 413–20.

62. Spiegel D, Bloom JR, Yalom I. Group support for patients with metatatic cancer. A randomized outcome study. Arch Gen Psychiatry 1981; 38: 527–533.

63. Spiegel D, Bloom JR. Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 1983; 45: 333–9.

64. Andersen BL, Yang HC, Farrar WB, et al. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer 2008; 113: 3450–8.

65. Andersen BL, Thornton LM, Shapiro CL, et al. Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clin Cancer Research 16: 3270–8.

66. Spiegel D. A 43-year-old womancoping with cancer. JAMA 1999; 282: 371–8.

67. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology and cancer: fact or fiction? European Journal of Cancer 1999; 35: 1603–7.

68. Antonijevic IA . Depressive disorders – is it time to endorse different pathophysiologies? Psychoneuroendocrinology 2006; 31: 1–15.

69. Riley V . Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 1975; 189: 465–7.

70. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 1981; 212: 1100–9.

71. Sapolsky RM, Donnelly TM. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology 1985; 117: 662–6.

72. Sapolsky R, Krey L, McEwan BS. Prolonged glucocorticoidexposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985; 5: 1222–1227.

73. Jayo JM, Shively CA, Kaplan JR, et al. Effects of exercise and stress on body fat distribution in male cynomolgus monkeys. Interbational Journal of Obesity&Related Metabolic Disorders 1993; 17: 597–604.

74. Epel E, McEwen B, Seeman T, et al. Psychological stress and lack of cortisol habituation among women with abdominal fat distribution. Psychosom Med 1999; 61:107.

75. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998; 21: 293–307.

76. Posener JA, Schildkraut JJ, Samson JA, et al . Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology 1996; 21: 33–8.

77. David Spiegel. Mind matters in cancer survival. Psychooncology 2012; 21(6): 588–593.

78. Sheridan JF, Dobbs C, Jung J, et al. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann N Y Acad Sci 1998; 840: 803–8.

79. Sheridan JF. Stress-induced modulation of anti-viral immunity – Normal Cousins Memorial Lecture1997; Brain, Behav, Immun 1998; 12: 1–6.

80. Padgett DA, Loria RM, Sheridan JF. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J Neuroimmunol 1997; 78: 203–11.

81. Glaser R, Kiecolt-Glaser JK. Stress associated immune modulations: relevance to viral infections and chronic fatigue syndrome. American Journal of Medicine 1998; 105: 35S–42S.

82. Kiecolt-Glaser JK, Glaser R, Cacioppo JT, et al. Marital stress: immunologic, neuroendocrine, and autonomic correlates. Ann N Y Acad Sci 1998; 840: 656–63.

83. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility too the common cold. N Engl J Med 1991; 325: 606–12.

84. Garssen B, Goodkin K. On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psyciatry Res 1999; 85: 51–61.

85. Reynolds P, Hurley S, Torres M, Jackson J, Boyd P, Chen VW . Use of coping strategies and breast cancer survival: results from the Black/White cancer survival study. Am J Epidemiol 2000; 152: 940–948.

86. Garssen B, Remie M. Different concepts or different words? Concepts related to non-expression of negative emotions.In Emotional Expression and Health 2004, Nyclicek I, Temoshok L, Vingerhoets A, pp 117–136. Hove and New York: Brunner-Routledge.

87. Butow PN, Coates AS, Dunn S. Psychosocial predictors of survival: metastatic breast cancer. Ann Oncol 2000; 11: 469–474.

88. Butow PN, Coates AS, Dunn SM. Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 1999; 17: 2256–2263.

89. Folkman S, Chesney M, McKusick L, Ironson G, Johnson DS, Coates TJ. Translating coping theory into an intervention.In: The Social Context of Coping, Eckenrode J, pp 239–260. New York: Plenum Press.

90. Burgess C. Stress and cancer. Cancer Surv 1987; 6: 403–416.

91. Temoshok L. Personality, coping style, emotion and cancer: towards an integrative model. Cancer Surv 1987; 6: 545–567.

92. Dolbeaut S, Szporn A, Holland JC. Psycho-oncology: where have we been? Where are we going? Eur J Cancer 1999; 35: 1554–1558.

93. Gross J. Emotional expression in cancer onset and progression. Soc Sci Med 1989; 28: 1239–1248.

94. Greer S, Watson M. Towards a psychobiological model of cancer: psychological considerations. Soc Sci Med 1985; 20: 773–777.

95. Petticrew M, Bell R, Hunter D. Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 2002; 325: 1066–1069.

96. Grossarth-Maticek R, Bastiaans J, Kanazir DT. Psychosocial factors as strong predictors of mortality from cancer, ischaemic heart disease and stroke: the Yugoslav prospective study. J Psychosom Res 1985; 29: 167–176.

97. van der Plog HM, Kleijn WC, Mook J, van Donge M, Pieters AMJ, Leer J-WH. Rationality and antiemotionality as a risk factor for cancer: concepts differentiation. J Psychosom Res 1989; 33: 217–225.

98. Swan G, Carmelli D, Dame A, Rosenman R, Spielberger C. The rationality/emotional defensiveness scale II. Convergent and discriminant correlational analysis in males and females with and without cancer. J Psycosom Res 1992; 36: 349–359.